The Drug Market Is Evolving: Emerging Synthetic Drugs Pose Novel Health Hazards in Homes and Cars
Safety Services Management Conducts Advanced Trace-Level Testing to Detect New Illicit Drugs in the Market
Illegal drugs are evolving rapidly.
Fentanyl remains a significant issue, but law enforcement and public health officials are also watching other synthetic opioids, sedatives commonly used in veterinary medicine, synthetic and designer benzodiazepines, and other new psychoactive substances.
Key Takeaways
DEA says illegal fentanyl is now being mixed with nitazenes, cychlorphine, medetomidine, and xylazine.
Some of these drugs are much stronger than fentanyl. Others aren't opioids at all, so naloxone may not fully reverse them.
Drug residue can stay on surfaces in homes and vehicles long after the drug use stops, even when nothing is visible.
SSM tests with the handheld MX908 mass spectrometer, which covers fentanyl, 2,000+ fentanyl analogs, xylazine, nitazenes, and newer targets like medetomidine and bromazolam.
On May 12, 2026, the U.S. Drug Enforcement Administration issued a public safety advisory stating that illegal fentanyl is now being combined with other drugs, including nitazenes, cychlorphine, medetomidine, and xylazine. Some of these drugs can be much more potent than fentanyl. Xylazine and medetomidine are not opioids, so naloxone may not fully reverse their effects, and nitazenes and cychlorphine may take several doses of naloxone.
DEA’s May 2026 public safety advisory on fentanyl mixed with emerging synthetic drugs.
For Safety Services Management (SSM), one more problem tied to the changing drug supply is drug contamination of homes, apartments, newly bought homes, crime scenes, and recovered stolen vehicles. People who enter these places often know very little about past drug use or other drug-related activity there.
Cychlorphine: Another Synthetic Opioid Development Has Led to 49 Deaths
The chemical structure of cychlorphine. Structure drawn from PubChem data (CID 201662).
One of the contaminants of concern is cychlorphine, or N-propionitrile chlorphine.
Cychlorphine is a newer synthetic opioid that belongs to a group known as "orphines." According to CFSRE, synthetic opioids like cychlorphine have increased recently as illicit producers have shifted away from other controlled synthetic opioids, such as nitazenes.
It has been found as a street drug by itself and in combination with other drugs, including fentanyl, xylazine, medetomidine, benzodiazepines, stimulants, and other synthetic opioids.
The data are troubling. As of May 18, 2026, DEA TOX had confirmed cychlorphine in 49 deaths of people aged 18 to 66. In five of those deaths, cychlorphine was found at low concentrations, either alone or with other drugs present at very low concentrations.
DEA's NFLIS-Drug data show 225 forensic encounters of cychlorphine in 19 states since 2022. Cychlorphine was temporarily placed in Schedule I on August 27, 2026 (Federal Register).
For SSM, cychlorphine is not just a new compound that we are monitoring. We have tested and validated methods for detecting cychlorphine using the MX908 and the 908 Devices Reachback process. These methods help us assess contamination risks as reports of cychlorphine in the illegal drug market increase.
Nitazenes: A New and Evolving Class of Highly Potent Opioids
A DEA hazmat team clears a clandestine pill-press lab in St. Albans. Seized pills made to look like oxycodone contained fentanyl or the nitazenes protonitazene and butonitazene. Photo: DEA
Nitazenes are a different type of drug. The term nitazene isn't the name of one drug but an evolving group of synthetic opioids.
DEA has identified 22 nitazene substances since 2020. New nitazene variations keep appearing as illegal drug producers modify their formulas to stay ahead of controlled-substance regulations and other law enforcement efforts.
In August 2026, DEA issued another alert after a surge in fatal overdoses in Louisiana's St. Tammany, Tangipahoa, and Washington Parishes. Some nitazenes are much more potent than fentanyl, and an overdose may take more than one dose of naloxone to reverse.
This is one area where trace detection is particularly useful.
908 Devices lists nitazenes as an MX908 capability, with many related compounds covered in on-instrument and off-instrument libraries and Reachback resources. Nitazenes may be present in a sample in trace amounts. An MX908 with trace-level mass spectrometry can outperform technologies built to analyze bulk powder samples.
Medetomidine: A New Threat Similar to "Tranq" Drugs
The chemical structure of medetomidine. Structure drawn from PubChem data (CID 68602).
Another compound becoming more common is medetomidine, a veterinary drug that has appeared in the illegal fentanyl market.
Unlike fentanyl and nitazenes, medetomidine is not an opioid. Naloxone can reverse an overdose involving opioids, but it has no effect on the sedative properties of medetomidine.
It has grown a lot.
Reports of medetomidine to the National Forensic Laboratory Information System rose from 247 in 2023 to 2,616 in 2024, a 950% increase. The number of reports rose to 8,233 in 2025 (CDC Health Alert).
Most reports have come from the Northeast and Midwest. The CDC has also found medetomidine, at lower levels, in drug samples tested in the Western United States.
For SSM, another practical consideration is that medetomidine was added to the MX908 target list with the v3.6 software release in February 2026.
Bromazolam: Fake Xanax and Fentanyl Blends
This fake “Xanax” bar was sold as alprazolam, but lab testing found bromazolam and caffeine instead. Photo: Pink Bee, Wikimedia Commons
Bromazolam is an increasingly common drug, especially in falsified medications.
It is a designer benzodiazepine, and tablets containing it can be manufactured to look like other prescription drugs, including Xanax and oxycodone. Appearance is therefore not a reliable guide to a tablet's contents.
DEA emergency scheduled bromazolam in March 2026. As of February 2026, DEA TOX had detected bromazolam in 259 cases, and about 78 percent of those cases also involved fentanyl (Federal Register).
Bromazolam has been added to the MX908 v3.6 target list, so SSM can add bromazolam to advanced trace tests as needed.
Emerging Synthetic Stimulants
Synthetic cathinones are often sold in packets labeled as “bath salts.” Photo: DEA
The changes do not just apply to opioids.
N-isopropyl butylone is a new synthetic cathinone, or stimulant, first identified by CFSRE in August 2024. It has been found in more than 40 samples submitted to CFSRE, including toxicology samples from fatal and nonfatal overdose cases. Other toxicology testing found it to be a common synthetic stimulant in 2025.
N-isopropyl butylone later became part of the updated MX908 v3.6 target set, as did two synthetic cannabinoids, ADB-PINACA and MDMB-BINACA.
The big picture is that the illegal market is not heading in one direction. New drugs are appearing in several different drug classes at once.
Fentanyl, Fentanyl Derivatives, and Xylazine Are Top Drug Threats
The MX908 identifies fentanyl and classifies more than 2,000 fentanyl analogs.
None of this implies that older threats are gone.
In fact, it is the reverse. New substances are often found in combination with other known harmful substances.
The MX908 can detect fentanyl and includes classification features for more than 2,000 fentanyl analogs. The MX908 can also detect xylazine, an additional drug sometimes found in fentanyl mixtures.
The ability to analyze mixtures is important. Drugs identified in current cases might include multiple substances, some well known and others new to the illegal market.
New Issue: Synthetic Opioids Based on Kratom Ingredients
A kratom “shot” whose label listed 7-hydroxymitragynine (7-OH). Brand label blurred. Photo: FDA
SSM is monitoring issues related to synthetic compounds derived from kratom.
In August 2026, the federal government temporarily placed mitragynine pseudoindoxyl (MGPI), MGM-15, and MGM-16 in Schedule I. All three are potent opioid receptor agonists chemically related to 7-hydroxymitragynine, also known as 7-OH (Federal Register).
The Department of Justice announced the emergency scheduling on August 25, 2026, citing an imminent hazard to public safety.
This is another reason to be careful when talking about new drug testing. SSM is following updates to the MX908 and the 908 Devices Reachback library. We are not claiming that every synthetic kratom analog is an MX908 target.
The chemistry is changing quickly, and you can't make many assumptions. Testing methods and other resources need to keep up.
Why Drug Testing for Traces Is Used in Homes and Cars
Drug contamination may not always be visible.
There may be no powder or other obvious sign that drugs were there. Residual traces of drugs can linger on surfaces even after the drug use has stopped.
The MX908 uses high-pressure mass spectrometry (HPMS) to test for trace chemical samples, including invisible residue. The 908 Devices website describes MX908 swab testing of surfaces and packaging, including residue you can't see.
How the MX908 handheld mass spectrometer identifies trace drugs and other chemical threats in the field.
The system can identify substances at low-nanogram levels and is designed to pick out common substances in mixtures, even with cutting agents and other additives present.
For SSM, there are many uses:
New home sales and existing homes where buyers are worried about past drug use and other illegal activity at the property.
Stolen and recovered vehicles, before their owners or other occupants get back in.
Rental and investment properties suspected of drug use.
Vehicles, buildings, and other areas where illegal drugs are being removed, including pre- and post-cleanup testing.
Properties where methamphetamine and fentanyl testing alone may no longer show the full picture of what was used there.
Vehicle testing focuses on the surfaces people touch most.
Vehicles offer many opportunities for trace testing. 908 Devices describes a real-world case in which the MX908 was used to swab steering wheels, door handles, the center console, and the glove box of a stolen vehicle, turning up drugs that may not otherwise be visible. Learn more about our recovered stolen vehicle drug testing.
SSM: Expanding Drug Testing Beyond Yesterday's Offerings
SSM tests and cleans drug-contaminated homes, rentals, and vehicles.
For many years, illegal drug investigations focused mainly on methamphetamine, cocaine, heroin, and fentanyl. These are still important drugs to test for. However, they represent only part of a changing drug market.
Cychlorphine, nitazenes, medetomidine, bromazolam, new cathinones, synthetic cannabinoids, and novel opioids are just a few reasons a modern investigation may need to go beyond a standard drug panel.
Safety Services Management uses the handheld MX908 mass spectrometer for trace analysis of known illicit drugs and other synthetic threats. If unknown spectra are detected or other synthetic threats are found, SSM can use 908 Devices Reachback drug identification services for further analysis. Safety Services Management has confirmed that it can test for cychlorphine. When testing finds contamination, our fentanyl remediation team handles the cleanup and clearance testing.
For a homebuyer, an insurance company dealing with a salvaged car, a property manager concerned about drug use, and others, this testing provides valuable information about a home, rental property, or recovered stolen vehicle. It answers one question:
What happened here before I arrived?
The availability of drugs is changing. Drug testing strategies need to change with it.
Recovered a stolen car? See how our recovered stolen vehicle illicit drug testing works.
Sources
DEA, Public Safety Advisory: Fentanyl Mixed with Emerging Synthetic Drugs (May 12, 2026): https://www.dea.gov/press-releases/2026/05/12/public-safety-advisory
CFSRE NPS Discovery, Increase in Fatal Overdoses Linked to N-Propionitrile Chlorphine (Cychlorphine) (Jan. 30, 2026): https://www.cfsre.org/nps-discovery/public-alerts/increase-in-fatal-overdoses-linked-to-novel-synthetic-opioid-n-propionitrile-chlorphine-cychlorphine
Federal Register, Temporary Placement of N-Propionitrile Chlorphine and Three Other Opioids in Schedule I, 91 FR 55252 (Aug. 27, 2026): https://www.federalregister.gov/documents/2026/08/27/2026-17531/schedules-of-controlled-substances-temporary-placement-of-56-dichloro-brorphine-56-dichloro
DEA New Orleans, Warning on Lethal Synthetic Opioids (Aug. 25, 2026): https://www.dea.gov/press-releases/2026/08/25/dea-new-orleans-warns-northshore-communities-lethal-synthetic-opioids
908 Devices, Trace Identification of Nitazenes: https://908devices.com/resource/trace-identification-of-nitazenes/
CDC Health Alert Network, Medetomidine in the U.S. Illegal Fentanyl Supply (Apr. 2, 2026): https://www.cdc.gov/han/php/notices/han00527.html
908 Devices, Enhances MX908 Usability and Adds New Drug Targets (Feb. 5, 2026): https://908devices.com/news/908-devices-enhances-mx908-usability-and-adds-new-drug-targets/
DEA, DEA Emergency Schedules Bromazolam (Mar. 18, 2026): https://www.dea.gov/press-releases/2026/03/18/dea-emergency-schedules-bromazolam
Federal Register, Temporary Placement of Bromazolam in Schedule I (Mar. 16, 2026): https://www.federalregister.gov/documents/2026/03/16/2026-05064/schedules-of-controlled-substances-temporary-placement-of-bromazolam-in-schedule-i
CFSRE NPS Discovery, New Synthetic Cathinone N-Isopropyl Butylone: https://www.cfsre.org/nps-discovery/public-alerts/new-synthetic-cathinone-n-isopropyl-butylone-exhibiting-increased-identifications-in-forensic-samples-in-the-u-s
908 Devices, MX908 product page: https://908devices.com/products/mx908/
908 Devices, MX908 and the Identification of Fentanyl/Xylazine Mixtures: https://908devices.com/blog/mx908-identification-of-fentanyl-xylazine-mixtures/
Federal Register, Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I (Aug. 26, 2026): https://www.federalregister.gov/documents/2026/08/26/2026-17429/schedules-of-controlled-substances-temporary-placement-of-mitragynine-pseudoindoxyl-mgm-15-and
U.S. Department of Justice, Emergency Scheduling of Three Potent Opioid Compounds (Aug. 25, 2026): https://www.justice.gov/opa/pr/justice-department-announces-emergency-scheduling-three-potent-opioid-compounds
908 Devices, Case Study: Aerosolized Fentanyl During Decontamination: https://908devices.com/resource/mx908-casestudy-aerosolized-fentanyl-during-decontamination/